Override key facts
as of Oct 2026- Operator of a digital healthcare platform intended to provide comprehensive care to control chronic suffering.
- Override is valued at approximately $23.5M as of Oct 2026 (last reported valuation).
- It has raised $6.3M; the latest was Seed Round ($6.3M) in Jun 2025.
- Notable investors include SignalFire, Martin Ventures, Corewell Health Ventures, 7wire Ventures, Confluent Health — 6 tracked in total.
- Status: Privately Held (backing).
Override's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·Watch Override: the Monday email on marks, rounds and moves
Override funding rounds
No funding rounds for Override are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Override valuation
Override's last reported valuation was $23.5 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Override investors
6 investors are on record for Override, including SignalFire, Martin Ventures, Corewell Health Ventures and 7wire Ventures.
About Override
Operator of a digital healthcare platform intended to provide comprehensive care to control chronic suffering. The company's platform offers online access to pain specialists in pain medicine, physical therapy, psychology, and coaching to create personalized treatment plans, enabling patients living with chronic pain to manage their condition, reduce symptoms, and improve their quality of life.
- Sector
- Healthcare
- HQ
- Middletown, DE, United States
- Founded
- 2021
- Employees
- 44
- Website
- override.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.